Press

The DESTINIES Study: an online Delphi study to build international consensus on the medical conditions and procedures that confer immunosuppression and their respective COVID-19 risk profiles

Lancet eClinicalMedicine

Defining and Risk-Stratifying Immunosuppression (the DESTINIES Study): Protocol for an Electronic Delphi Study

JMIR Research Protocols

DESTINIES phenotype extract-ready codelist - Systemized Nomenclature of Medicine Clinical Term (SNOMED-CT) compatible

Access file here

Build the consensus